Nabilone and Diazepam Interaction

Drug interaction information between Nabilone and Diazepam.

Nabilone and Diazepam have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Nabilone and Diazepam. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Nabilone

Cannabinoid Antiemetic

Drug B

Diazepam

Benzodiazepine

How They Interact

Both drugs slow down the brain and body, which can lead to a combined effect that makes it much harder to move or think clearly.

FDA Label Information

Drug Interactions Potential interactions between Cesamet 2 mg, and diazepam 5 mg; sodium secobarbital 100 mg; alcohol 45 mL (absolute laboratory alcohol); or codeine 65 mg, were evaluated in 15 subjects. Psychomotor function was particularly impaired with concurrent use of diazepam.

Diazepam Also Interacts With

View all Diazepam interactions →

Frequently Asked Questions

What SPL severity band is on file for Nabilone + Diazepam?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Diazepam has 26 labeled pairs on file vs Nabilone's 11. In the minor band specifically: Nabilone has 11 (also Fluoxetine, Buspirone, Amitriptyline, Lithium); Diazepam has 22 (also Omeprazole, Ketoconazole, Fluvoxamine, Cimetidine).

What mechanism field is on file for Nabilone and Diazepam?

Both drugs slow down the brain and body, which can lead to a combined effect that makes it much harder to move or think clearly.

Diazepam's labeled portfolio outnumbers Nabilone

SPL source-record counts only. This page's band is minor · classes on file: Nabilone (Cannabinoid Antiemetic); Diazepam (Benzodiazepine).

Nabilone

0 major · 0 moderate · 11 minor · 11 total

Diazepam

0 major · 4 moderate · 22 minor · 26 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.